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Abstract
BACKGROUND: Cardiovascular disease is the number one cause of death in women worldwide. Preeclampsia may 
be more than just risk factor for the development of cardiovascular disease later in life. Systematic reviews suggested 
approximately double the risk of ischemic heart disease, cerebrovascular incidents, and mortality of cardiovascular 
disease after preeclampsia.
AIM: The aim of the study was to analyze the differences of cardiovascular risk later in life-based on atherogenic index 
plasma and Framingham risk score (FRS) in postpartum women with preeclampsia compared with normotensive women.
METHODS: This is study a comparative analytic study with case–control design on 46 subjects, divided by 23 
postpartum preeclampsia patients as a case sample subject and 23 postpartum with no history of hypertension as 
the control group. Subjects were examined for blood pressure, height, weight, and asked to fast for at least 8 h before 
blood lipid profile and glucose were examined with laboratory methods. Atherogenic index plasma and FRS were 
measured. Data were analyzed using SPSS version 25. p < 0.05 was considered significant.
RESULTS: Based on the results, the study found significant differences between systolic and diastolic blood pressure 
in preeclampsia compared to the control group. Median systolic and diastolic blood pressure in the preeclampsia 
group compared to control group were 180 versus 110 in systolic blood pressure; 100 versus 80 in diastolic blood 
pressure with p < 0.000. Total cholesterol, low-density lipid, high-density lipoprotein, and triglycerides levels in 
preeclampsia were 218.38 ± 23.26 mg/dL, 128.60 ± 22.74 mg/dL, 38.60 ± 5.99 mg/dL, and 252.73 ± 47.16 mg/dL, 
respectively, with p < 0.05 and non-preeclampsia group were 143.0 ± 16.82 mg/dL, 69.17 ± 23.03 mg/dL, 51.73 ± 
8.65 mg/dL, and 121.30 ± 14.65 mg/dL, respectively, with p < 0.05. Differences in plasma atherogenic index values 
can clearly be observed in the preeclampsia and control groups (p < 0.05). A similar interpretation was found in the 
FRS (p < 0.05). There was a significant positive correlation between age and body mass index with atherogenic index 
plasma and FRS in preeclamptic group.
CONCLUSION: There was a significant difference in atherogenic index plasma and Framingham risk score of 
postpartum preeclampsia and normotensive women.
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Introduction
According to the World Health Organization 
(WHO), cardiovascular disease is the number one 
cause of death in the world [1]. Statistical data in Europe 
show higher mortality from cardiovascular disease in 
women than in men (49% vs. 41%) [2], and the same 
prevalence was found in Indonesia [3]. In addition to 
dyslipidemia, hypertension, smoking, obesity, diabetes 
mellitus, genetics, and physical inactivity, women have 
special risk factor, “diseases related to reproduction 
and pregnancy [4], [5].” One of those is preeclampsia. 
Preeclampsia is a vascular disorder, in which women 
with hypertension at 20 weeks of gestation accompanied 
by signs of other organ dysfunction [6]. Observational 
studies revealed an increased risk of long-term 
cardiovascular disease in women who experience 
various types of gestational hypertension disorders 
and preeclampsia. In 2011, the American Heart 
Association (AHA) added a history of preeclampsia 
as an independent risk factor for cardiovascular 
disease 10–15 years after pregnancy [7]. A history of 
preeclampsia needs special attention, because based 
on epidemiological studies; it may trigger premature 
cardiovascular disease [8].
Association between preeclampsia with 
the risk of cardiovascular disease in the future is 
incompletely understood [8]. Bellamy et al. suggested 
that hypertension in pregnancy does not cause 
cardiovascular changes, instead maternal risk factors 
before pregnancy determine cardiovascular risk later 
in life [9]. In contrast to that study, Hromadnikova 
et al. suggested that the risk of heart disease later 
develops due to epigenetic changes related to 
pregnancy complications. The hypothesis suggests 
that acute atherosis of the spiral arteries by obliteration 
of the endothelial lumen results in reduced placental 
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perfusion, local ischemia, and the onset of oxidative 
stress. This is caused by the production of excessive 
reactive oxygen species that induce lipid peroxidation 
production. Both of these species are known to be 
the main mediators of systemic and inflammatory 
vascular dysfunction. Some studies show a decrease in 
vascular endothelial function for months or even years 
after preeclampsia. Preeclampsia and atherosclerosis 
have certain similarities; both are associated with 
dyslipidemia, endothelial dysfunction, and elevated 
levels of pro-inflammatory cytokines. Abnormal lipid 
profiles are strongly associated with atherosclerotic 
cardiovascular disease and have a direct effect on 
endothelial dysfunction [10], [11], [12].
AHA and National Institute for Health and 
Clinical Excellence recommend preventative strategies 
for cardiovascular events in women with a history of 
preeclampsia [13]. The predictive capacity of several 
lipoprotein ratios has been shown to be better for 
screening purposes. One of them is atherogenic index of 
plasma (AIP) which most sensitive marker than a single 
lipid marker and recently as a marker of atherogenicity 
because it is increased in people with a higher risk 
for coronary heart disease. Another cardiovascular 
risk assessment is the Framingham risk score (FRS). 
This scoring system has been used extensively, even 
recommended by the national cholesterol education 
adult treatment program because it can estimate the 
risk of heart disease in the next 10 years and is proven 
to be close to the observed risk. This scoring system 
not only assesses lipid profiles but also includes other 
cardiovascular risk factors [12], [14], [15], [16].
In general, in Indonesia, postpartum 
preeclampsia patients would only get short-term care 
and have lower tendency for complete postpartum 
care, in that case, health care providers cannot 
provide management for the long-term effects after 
preeclampsia. The aim of this study is to assess the 
differences in risk of cardiovascular disease 1 day 
postpartum in preeclampsia and normotensive patients. 
Cardiovascular risk assessment is based on an AIP 
and FRS to assess the risk for the next 10 years. If 
differences are found, it can be used as one of the 
means for postpartum risk screening for cardiovascular 
disease in the future.
Materials and Methods
This study is a comparative analytic study 
with case–control design on 46 subject divided by 23 
postpartum preeclampsia patients as a case group 
and 23 postpartum with no history of hypertension as 
a control group. Subjects were patients who delivered 
at Haji Adam Malik Hospital Medan and Universitas 
Sumatera Utara affiliate hospitals between January 
2019 and June 2019. Subjects were selected according 
to inclusion and exclusion criteria. Preeclampsia 
patients who met the criteria for diagnosis preeclampsia 
with severe feature according to Indonesian National 
Clinical Guideline 2016 and control group who were 
normotensive during pregnancy were included in this 
study. All the subjects were ≥30 years old. A thorough 
history and physical examination were done and 
patient with a history of hypertension, diabetes 
mellitus, cardiovascular disease, autoimmune disease, 
cerebrovascular disease, hepatic disease, thyroid 
gland, and kidney disease and with history of long-
term drugs usage except for vitamins before and during 
pregnancy were excluded from this study. Informed 
consents were taken from all the patients included in the 
study. The study was approved by the Health Research 
Ethical Committee No 56/TGL/KEPK FK USU-RSUP 
HAM/2019, Faculty of Medicine, University of North 
Sumatera, Indonesia.
Blood pressure was measured using a 
mercury sphygmomanometer. Subjects were asked 
to fast for at least 8 h. Blood specimen was collected 
by venipuncture. 2 mL EDTA blood was examined for 
blood lipid profile and blood glucose by clinical chemical 
methods. Atherogenic index plasma was calculated 
using the values of lipid parameter in the following way:
Atherogenic index plasma = log
HDL - c
Triglyceride
FRS was calculated using Canadian 
Cardiovascular Society FRS, Table 1.
Table 1: Characteristic of patients with postpartum 
preeclampsia and normotensive
Characteristic subject Case Control p-value
n % n %
Age (years) 0.659
30–34 13 56.5 11 47.8
35–39 8 34.8 8 34.8
40–44 2 8.7 4 17.4
>45 0 0
Paritas 0.039
Primiparity 9 39.1 2 8.7
Secundi-multiparity 14 60.9 20 87.0
Grande-multiparity 0 0 1 4.3
BMI 0.007
Underweight 0 0
Normoweight 9 39.1 16 69.6
Overweight 6 26.1 7 30.4
Obesity 8 34.8 0 0
Activity 0.459
Housewife 20 87.0 17 73,9
Active worker 3 13 6 26.1
p-value assessed using Chi-square.
Statistical analysis
Data were analyzed using Statistical Package 
for the Social Sciences (SPSS version 25 IBM corp.). 
Statistical tests performed were Mann–Whitney U-test 
(for blood pressure and cardiovascular risk assessment 
because of non-normal distributed data) and independent 
t-test (for lipid profile because normal distribution data). 
Correlation between the variables in preeclampsia group 
was estimated by spearman’s Rho. p < 0.05 was applied 
to each statistical test and was declared significant.
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Results
Characteristics of case and control group
Most of the subject in both groups were aged 
between 30 and 34 years old, the case group 56.5% 
and controls 47.8%. Both groups have found the same 
percentage (34.8%) of subjects aged 35–39 years old. In
Table 3: Lipid Profile of patients with postpartum preeclampsia 
and normotensive
Lipid profile Case Control p-value
Mean ± SD Mean ± SD
Total cholesterol 218.39 ± 23.26 143.0 ± 16.82 0.000
LDL 128.60 ± 22.74 69.17 ± 23.03 0.000
HDL 38.60 ± 5.99 51.73 ± 8.65 0.000
Triglycerides 252.73 ± 47.16 121.30 ± 14.65 0.000
p-value assessed using T-independent test.
the case group, there were fewer (8.7%), patients aged 
40–44 years compared to the control group (17.5 %) 
with p > 0.05. Nine women (39.1%) were primiparas 
and 14 women were secundi-multiparity (60.9%) in the 
case group, whereas in the control group, 2 women 
(8.7%) were primiparity, 20 women (87%) were secundi-
multiparity, and just 1 woman was grand-multiparity 
(4.3%) with p < 0.05. Underweight patients was not 
found in both groups, normoweight in 9 cases (39.1%) 
Table 4: Cardiovascular risk assessment of patients with 
postpartum preeclampsia and normotensive
Cardiovascular risk assessment Case Control p-value
AIP 0.43 (0.31–0.95) 0.20 (−0.16–0.23) 0.000
FRS 6.30 (5.30–11.7) 1.70(1.80–3.90) 0.000
Values are median (min-max). p-value assessed using Mann–Whitney U-test. AIP: Atherogenic index of 
plasma.
and 16 (69.6%) in control group, overweight in 6 case 
(26.1%) and 7 control group (30.4%), obesity was found 
in 8 women in case group (34.8%) with p < 0.05. Based 
on activity, housewife was found in 20 case (87%) and 
17 control group (74%), while active workers in 3 case 
(13%) and 6 control group (26%) with p > 0.05. All 
women in the study subjects (100%) did not have a 
history of smoking either before pregnancy or during 
pregnancy. It is found that late-onset preeclampsia has 
a greater frequency of 56.5% compared to 43.5% early-
onset preeclampsia in this study.
Table 5: Correlation between age, parity, and body mass 
index with cardiovascular risk assessment of patients with 
postpartum preeclampsia (case) subjects
Cardiovascular risk 
assessment
Age Parity Body mass index
r-value p-value r-value p-value r-value p-value
AIP 0.585 0.003 0.242 0.266 0.610 0.002
FRS 0.864 0.000 0.519 0.011 0.520 0.011
AIP: Atherogenic index of plasma, FRS: Framingham risk score. r-value and p-value assessed using 
spearman Rho correlation test.
Median systolic and diastolic blood pressure were 
180 (150–200); 100 (90–120) in the preeclampsia group 
and 110 (100–130); 80 (60–90) in the non- preeclampsia 
group (p < 0.05), Table 2.
Lipid parameters were significantly different 
between the preeclampsia and control group 
(p < 0.05). The average total cholesterol, low-density lipid 
cholesterol (LDL-c), high-density lipoprotein cholesterol 
(HDL-c), and triglyceride (TG) levels, respectively, in 
the preeclampsia group were 218.39 ± 23.36 mg/dL, 
128.6 ± 22.74 mg/dL, 38.6 ± 5.99 mg/dL, and 252.73 ± 
47.16 mg/dL, whereas in the control group was 143 ± 
16.8 mg/dL, 69.17 ± 15.77 mg/dL, 51.73 ± 8.65 mg/dL, 
and 121.3 ± 14.64 mg/dL, Table 3.
Median atherogenic index plasma was 
0.43 (0.31–0.95) in the preeclampsia group and 0.20 
(−0.16–0.23) in the control group (p < 0.05). A similar 
interpretation was found in the FRS, which was 
6.30 (5.30–11.7%) in the preeclampsia group and 
1.70 (1.8–3.90%) in the control group (p < 0.05). Further, 
the average interpretation of plasma atherogenic index 
values in the preeclampsia group is classified as 
high risk while in the low-risk control group, whereas 
according to Framingham the score is >5% in all cases 
group and <4% in the control group, although all are 
classified as low risk, Table 4.
Atherogenic plasma index and FRS had a 
significant correlation with age and body mass index 
(BMI), but the atherogenic plasma index does not have 
a significant correlation with parity in the preeclampsia 
group, Table 5.
Discussion
Atherogenic index plasma and FRS are 
significantly different in postpartum preeclampsia and 
normotensive groups (p < 0.05), respectively. The 
AIP parameter was significantly correlated with BMI 
and age but did not correlate significantly with parity. 
FRS parameter correlates with all of them. Similar with 
Aragon-Charris et al. which assessed the atherogenic 
plasma index in preeclamptic women, their results 
indicate that patients with severe preeclampsia and mild 
preeclampsia have significantly higher AIP, TG, and 
LDL cholesterol values than pregnant controls and the 
group of patients with preeclampsia shows significantly 
lower HDL values when compared to normotensive 
pregnant women [17].
Singh demonstrated that there was an 
extremely significant increase in the plasma atherogenic 
index (p < 0.0001) in the case group compared to the 
control group, 0.3776 ± 0.6592 and 0.2944 ± 0.01178, 
respectively; the average AIP value was higher in 
preeclampsia women compared to the control group 
so it can be concluded that plasma lipid levels tend 
to be higher in preeclampsia. AIP value >0.24 was 
found in 48% of preeclampsia women and 36% were 
normotensive women, while the value of AIP ≤0.24 
was found in 2% of preeclampsia women and 14% of 
Table 2: Blood pressure of patients with postpartum 
preeclampsia and normotensive
Blood pressure Case Control p-value
Systolic 180 (150–200) 110 (100–130) 0.000
Diastolic 100 (90–120) 80 (60–90) 0.000
Values are median (min-max). p-value assessed using Mann–Whitney U-test.
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normotensive women. This indicates that women with 
AIP values >0.24 9.33 times more risk of experiencing 
cardiovascular risk later in life [12].
For FRS, in this study, both the case and 
control groups were classified as low risk (<10%), but 
Framingham scores in preeclampsia patients had a 
higher risk value than in the control group of 5.5% and a 
maximum of 11.7% while in the control group a minimum 
value of 1.0% and a maximum of 3.9%. The same 
research results obtained from Christensen et al. This 
study used the FRS (more focused on lipid parameters 
and BMI) to evaluate the risk of cardiovascular disease 
in the next 10- and 30-year in women with preeclampsia 
and normotension. Outcomes were found to be higher in 
preeclampsia women, although significant results were 
found in the 10-year FRS with focal point BMI (3.9 vs. 
3.0, p = 0.03). This study concludes that this FRS is 
best used for primary preventive purposes [8], [18].
Average 10- and 30-year cardiovascular 
risk according to the FRS that has been traced by 
Breetvald et al. gave comparable results between the 
preeclampsia and control groups, 1.6% versus 1.5% 
(p = 0.22) and 9.0% versus 9.0% (p = 0.49). However, 
women with hypertension after preeclampsia are twice 
as likely to develop cardiovascular disease as those 
who normalize to return after preeclampsia; average 
10- and 30-year cardiovascular risk according to the 
FRS was 3.1% versus 1.5% (p < 0.01) and 19.0% 
versus 8.0% (p < 0.01), respectively. When explored 
further, early-onset preeclampsia was more frequent in 
women who continued hypertension after preeclampsia 
and showed a higher risk of cardiovascular disease 
compared to advanced onset preeclampsia: 1.7% 
versus 1.3% (p < 0.05) and 10.0% versus 7.0% 
(p < 0.05), respectively [19].
Smith et al. also calculated the risk of 
cardiovascular disease in women after pregnancy with 
both preeclampsia (99 people) and not (118 people). 
The results showed that 18.2% of preeclampsia women 
and 1.7% of high-risk normotensive women suffering 
from cardiovascular disease in the next 10 years were 
13 times (odds ratio [OR] 13.08; 95% confidence 
interval CI 3.38–85.5), 31.3% of preeclampsia women 
and 5.1% of high risk normotensive women suffering 
from the next 30 years were 8 times (OR 8.43; 95% CI 
3.48–23.23), and the lifetime risk was 3 times higher 
(OR 3.25; 95% CI 1.76–6.11) in 41.4% of preeclampsia 
women and 17.8% of women normal [20].
In addition to studies assessing future 
cardiovascular risk, several studies have been carried 
out to prove the real cardiovascular damage after 
preeclampsia. One of them was carried out by Melchiorre 
et al., this study evaluating left ventricular disorders in 
patients with preeclampsia 1–2 years postpartum. The 
result is that patients with a history of preeclampsia 
have 2 years postpartum essential hypertension that 
is statistically significant with moderate to severe 
impairment of function and shape in the left ventricle. 
Therefore, it is recommended to assess the risk of heart 
disease 1–2 years of postpartum to provide benefits 
and therapeutic intervention [21].
Lipid metabolism is an important key 
pathophysiology of preeclampsia. In normal pregnancy, 
TG and plasma cholesterol levels increase and over 
time, the levels return to normal after delivery. Hormonal 
variations during pregnancy affect lipid metabolism. 
Female endogenous sex hormones significantly 
influence serum lipids. During pregnancy, hepatic 
lipase activity increases and lipoprotein lipase activity 
decreases. Hepatic lipase is responsible for increasing 
the synthesis of TGs in the liver, whereas decreased 
lipoprotein lipase activity also reduces the effects of 
catabolism in adipose tissue, resulting in increased TG 
in the circulation and the second step of uptake of the 
remaining chylomicrons by the liver is inhibited. Another 
hypothesis is that hypertriglyceridemia is thought to be 
a consequence of competition between chylomicrons 
and very LDL-c (VLDL-c) at lipoprotein lipase levels. 
Chylomicron clearance occurs through two important 
stages: Hydrolysis of TG by lipoprotein lipase and the 
remaining uptake by liver tissue. The inhibition in the 
second stage triggers accumulation in plasma and 
eventually becomes an atherogenic risk triggered 
by hypertriglyceridemia. Lipoproteins are rich in TG 
associated with inflammation, one of which is through 
VLDL particles that carry apoC-III. ApoC-III can increase 
molecular bonds in endothelial cells, strengthen bonds 
with monocytoid cells [14], [22], [23].
Gestational hyperlipidemia plays a physiological 
role to supply both cholesterol and TG rapidly for fetal 
development. Maternal TG levels are hydrolyzed 
in maternal lipoprotein receptors by lipoprotein fan 
lipase transported through the placenta through fatty 
acid-binding protein. TG play a role as regulators in 
lipoprotein interactions. This is supported by evidence 
that an increase in plasma concentration is associated 
with an increased incidence of coronary artery disease, 
an increase in the number of VLDL cholesterol particles 
and an increase in the potential for the transfer of a 
cholesterol ester mass from HDL cholesterol to a 
lipoprotein containing apolipoprotein [24], [25].
Normal pregnancy is associated with increased 
levels of TG, total cholesterol, and HDL-c. In the first 
trimester, an increase in deposition and hypertrophy 
of maternal fat stores with increased expression of 
insulin receptors such as glucose is available to meet 
the metabolic needs of the developing fetus. Increased 
maternal insulin and progesterone trigger lipogenesis 
as lipid production is produced, which is transported 
across the placenta and is metabolized for infant growth. 
These changes are generally non atherogenic and 
return to normal after delivery. Preeclampsia women had 
abnormal lipid results. Limited data regarding the effects 
of high blood pressure on lipid levels but new-onset 
preeclampsia triggers an increase in atherogenic lipid 
parameters with a decrease in cardioprotective HDL [25].
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Barry et al. in his study stating that uncomplicated 
postpartum women, visceral fat correlated independently 
with insulin sensitivity, blood pressure, and phenotypes 
of atherogenic lipoproteins whereas BMI and total body 
fat were not related. Intra-abdominal fat plays a role in 
pathophysiology as a source of free fatty acids, tumor 
necrosis factor-α, and plasminogen activator inhibitor-1 
which contribute to the risk of cardiovascular disease 
through pro-inflammatory effects, oxidative stress, 
fibrinolysis disorders, and increased angiotensin II 
production. Women with a history of preeclampsia have 
an atherogenic lipid profile and endothelial dysfunction 
compared to the control group despite having the same 
adiposity and insulin sensitivity. This suggests that 
there are separate mechanisms of obesity and insulin 
resistance that lead to cardiovascular risk factors in 
normal pregnancy and preeclampsia [26], [27].
In the case of preeclampsia, changes in lipid 
metabolism are triggered and are a major cause of 
endothelial dysfunction which reduces the effects of 
vasodilation-anticoagulation, increased expression of 
adhesion molecules, and release of cytokines-production 
of reactive oxygen species. Bellamy et al. confirmed 
that women with a history of preeclampsia showed 
an increased risk of hypertension (RR = 3.7), venous 
thromboembolism (RR = 1.79), and stroke (RR = 1.81). 
These findings confirm a possible relationship between 
hypertension in pregnancy and future cardiovascular 
disease. Lipids trigger hypertension through oxidative 
stress, then vascular endothelial proliferation and 
hypertrophy and collagen deposition that trigger 
thickening of the vascular media intima and narrowing 
of the lumen of blood vessels. Lipid peroxide stimulates 
thromboxane synthesis and inhibits endothelial-derived 
relaxing factor leading to vasoconstriction. Usha et al. 
and Bhardwaj et al. found dyslipidemia in preeclampsia 
women increases atherogenicity. In fact, Barden et al. 
found persistent 6-week postpartum lipid peroxidation 
in preeclampsia women; another important fact is 
that vascular lesions on the placental bed are similar 
to atherosclerotic plaques. Premature cardiovascular 
mortality is found to be higher in Asian-Indian races. 
The first episode of myocardial infarction under 40 years 
affects nearly 4.4% of women of this race (2–3.5 times 
higher than European women) [12].
Women with a history of preeclampsia have a high 
prevalence of several major cardiovascular risk factors. 
Although the estimated risk of a 10-year cardiovascular 
disease is low (<10%) after delivery, the number is still higher 
compared to normal postpartum. Framingham scores are 
strongly influenced by age at screening; therefore, even 
though in this study, FRS in the low-risk group but the risk of 
cardiovascular disease will increase rapidly with age if other 
factors are not controlled. The significant positive correlation 
of BMI with AIP and FRS values illustrates that postpartum 
preeclampsia patients need to modify lifestyle, maintain 
ideal body weight, and increase physical activity. National 
Guidance in the United States and the United Kingdom 
recommend that after a diagnosis of preeclampsia, women 
should be counseled and followed up for cardiovascular 
risk modification. As limitations of this study, the increase 
in AIP and FRS were influenced by BMI and age. These 
factors may be in the same causal factors between 
preeclampsia and cardiovascular disease. More research 
is needed with a larger number of samples and matching 
adjustments. It is also important to evaluate the risk factors 
for the cardiovascular disease before pregnancy to reduce 
the confounding factor. 
Conclusion
There was a significant difference in 
atherogenic index plasma and framingham risk score 
of postpartum preeclampsia compared to normotensive 
women.
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